Logo-bi
Original Research
Keyvan Yousefi, Fatemeh Fathiazad, Hamid Soraya, Maryam Rameshrad, Nasrin Maleki-Dizaji, Alireza Garjani*
Bioimpacts. 2014;4(1): 21-27. doi: 10.5681/bi.2014.001
PMCID: PMC4005279     PMID: 24790895     Scopus ID: 84900492052    
PDF
XML
Cited By:
Original Research
Hamid Soraya, Maryam Rameshrad, Aram Mokarizadeh, Alireza Garjani*
Bioimpacts. 2015;5(1): 3-8. doi: 10.15171/bi.2015.02
PMCID: PMC4401166     PMID: 25901291     Scopus ID: 84924853787    
Editorial
Ali Pourali, Yadollah Omidi* ORCID
Bioimpacts. 2023;13(2): 85-88. doi: 10.34172/bi.2023.22023
PMCID: PMC10182445     PMID: 37193078     Scopus ID: 85152106674    
Professor Yadollah Omidi has a Ph.D. degree in Pharmaceutical Sciences (2003, Cardiff University, UK) and completed a postdoctoral program (2004) at Cardiff University. He is currently working as a full professor at Nova Southeastern University College of Pharmacy, Florida. Prof. Omidi’s research in advanced targeted diagnosis and therapy of diseases have resulted in over 300 published papers in international journals, 27 book chapters, and a few patents.


As a peer-reviewed international open-access journal, BioImpacts publishes articles on basic and translational aspects of pharmaceutical and biomedical sciences. 
Acceptance rate: 24% 
Publication fee: Free of charge